Last week we welcomed Katja Nolvi to the Helsinki office.
Katja is a seasoned professional with nearly 20 years of experience in the pharmaceutical industry, specializing in Real-World Evidence, Market Access, Health Economics, and Outcomes Research (HEOR). Her career spans a […]
So efficient in fact, that the only photo we managed to get of it all was the wonderful view of our dinner venue.
Quantify has worked with Finnish data and access for years, but our new local team has already begun […]
Quantify’s Jonas Banefelt and Nicholas Norton will be on site and ready to connect.
Keep a lookout for booth #6 to have a chat and learn more about Quantify’s work with IFPA and get more information about our services and expertise.
Or why not get in […]
When living in a country that is dark and snowy for 6 months of the year, summer is a big deal and something worth celebrating. 🎉
Last Wednesday our Nordic colleagues got together for our annual summer party at Södra Teatern […]
Mathias Lilja joined Quantify Research 6 years ago as a Research Analyst. In his current role as Senior Lead Analyst within the Real World Evidence & Analysis unit, Mathias has become an integral part […]
Quantify’s Olivia Ernstsson and Alexandra Cooper are attending the Nordic Conference of Epidemiology and Register-Based Health Research (NordicEpi) in Copenhagen!
Olivia Ernstsson will give a poster presentation about NORDSTAR – a Nordic collaboration […]
This week we are welcoming a new colleague to our Copenhagen office!
Jacob Elskær Mollerup holds an engineering degree in Quantitative Biology and Disease Modelling from DTU – Technical University of Denmark. Prior to starting […]
On June 3rd, FINOSE officially re-launched as JNHB (Joint Nordic HTA-Bodies).
Except for the name, news include a brand new web-page where information and supporting documents are available, and the inclusion of Iceland […]
We are excited to welcome Ville Perälä, who is joining Quantify Research this week as Country Manager in Finland.
Ville has been working in pharmaceutical business, both as a consultant and in pharma companies, for […]